CONSOLIDATED BALANCE SHEETS - USD ($)	Mar. 31, 2023	Mar. 31, 2022
CURRENT ASSETS
Cash and cash equivalents	$ 14,532,943	$ 17,072,419
Accounts receivable	0	127,965
Prepaid expenses and other current assets	557,623	956,623
TOTAL CURRENT ASSETS	15,090,566	18,157,007
Property and equipment, net	1,144,004	441,238
Right-of-use lease asset	1,151,909	696,698
Patents, net	1,650	2,200
Restricted cash	87,506	87,506
Deposits	33,305	33,305
TOTAL ASSETS	17,508,940	19,417,954
CURRENT LIABILITIES
Accounts payable	432,890	499,962
Due to related parties	214,221	155,742
Deferred revenue	0	344,547
Lease liability, current portion	269,386	126,905
Other current liabilities	588,592	696,893
TOTAL CURRENT LIABILITIES	1,505,089	1,824,049
Lease liability, less current portion	939,642	602,505
TOTAL LIABILITIES	2,444,731	2,426,554
COMMITMENTS AND CONTINGENCIES (Note 9)
STOCKHOLDERS’ EQUITY
Common stock, $0.001 par value, 60,000,000 and 30,000,000 shares authorized at March 31, 2023 and 2022, respectively; 22,992,466 and 15,419,163 shares issued and outstanding at March 31, 2023 and 2022, respectively	22,994	15,421
Additional paid-in capital	157,405,911	147,446,868
Accumulated other comprehensive loss	(6,141)	0
Accumulated deficit	(142,358,555)	(130,329,181)
TOTAL AETHLON MEDICAL, INC. STOCKHOLDERS’ EQUITY BEFORE NONCONTROLLING INTERESTS	15,064,209	17,133,108
NONCONTROLLING INTERESTS	0	(141,708)
TOTAL STOCKHOLDERS’ EQUITY	15,064,209	16,991,400
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY	$ 17,508,940	$ 19,417,954